Reboxetine - CaLiGraph

Property	Value
rdf:type	Investigational attention deficit hyperactivity disorder drug Nicotinic antagonist Drug: Re owl:NamedIndividual Morpholine Pfizer brand Potassium channel blocker Antidepressant Norepinephrine reuptake inhibitor Phenol ether Psychiatric medication Italian invention
rdfs:label	Reboxetine
owl:sameAs	dbr:Reboxetine
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Norepinephrine_reuptake_inhibitor http://en.wikipedia.org/wiki/Category:Morpholines http://en.wikipedia.org/wiki/Category:Pfizer_brands http://en.wikipedia.org/wiki/C19H23NO3 http://en.wikipedia.org/wiki/Category:Nicotinic_antagonists http://en.wikipedia.org/wiki/List_of_investigational_attention_deficit_hyperactivity_disorder_drugs http://en.wikipedia.org/wiki/Category:Potassium_channel_blockers http://en.wikipedia.org/wiki/Alpha-3_beta-4_nicotinic_receptor http://en.wikipedia.org/wiki/Farmitalia http://en.wikipedia.org/wiki/CYP3A4 http://en.wikipedia.org/wiki/Category:Norepinephrine_reuptake_inhibitors http://en.wikipedia.org/wiki/Category:Phenol_ethers http://en.wikipedia.org/wiki/List_of_psychiatric_medications_by_condition_treated http://en.wikipedia.org/wiki/Category:Italian_inventions http://en.wikipedia.org/wiki/Category:Antidepressants http://en.wikipedia.org/wiki/List_of_antidepressants http://en.wikipedia.org/wiki/List_of_drugs:_Re http://en.wikipedia.org/wiki/Pharmacology_of_antidepressants
skos:prefLabel	Reboxetine
skos:altLabel	Reboxetine § Efficacy reboxetine
clgo:alternativeName	Edronax, others
clgo:casNumber	71620-89-8 98769-84-7
clgo:chEMBL	383921
clgo:drugbank	DB00234
clgo:fdaUniiCode	947S0YZ36I L94J81YNNY
clgo:kegg	D08472
clgo:pubchem	127151

About: clgr:Reboxetine